meddevicedb.com FDA Device Reference

MODIFICATION TO LIQUID GLUCOSE (HEXOKINASE) REAGENT SET

K002199 Class II Traditional
Decision Date
2000-11-20
Sponsor / Applicant
Pointe Scientific, Inc.,

Technical Specification

510(k) Submission ID K002199
Product Code CFR
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1345
Decision Date 2000-11-20
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

MODIFICATION TO LIQUID GLUCOSE (HEXOKINASE) REAGENT SET received FDA 510(k) clearance under submission number K002199, sponsored by Pointe Scientific, Inc.,. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2000-11-20.

Classification & Regulation

This clearance is catalogued under FDA product code CFR and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.